Home > Healthcare > Pharmaceuticals > Vaccines > Respiratory Disease Vaccine Market

Respiratory Disease Vaccine Market Share

Report ID: GMI10115
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Respiratory Disease Vaccine Market Share

The respiratory disease vaccine industry is competitive in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel vaccines with improved efficiency and cost-effectiveness are key market strategies for respiratory disease vaccine manufacturers, driving competition and innovation in the industry. This emphasis on innovation aims to address evolving clinical needs and enhance patient outcomes, positioning companies to gain market share and meet the growing demand for novel respiratory disease vaccines.

Respiratory Disease Vaccine Market Companies

Some of the eminent market participants operating in the respiratory disease vaccine industry include:

AstraZeneca
Emergent BioSolutions Inc.
GSK plc.
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Novavax
Pfizer Inc.
Sanofi SA
Serum Institute of India Pvt. Ltd.
SINOVAC

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Respiratory disease vaccine industry size was USD 65 billion in 2023 and will depict 4.1% CAGR from 2024 to 2032, owing to the rising incidence of respiratory infections like influenza, COVID-19, and pneumococcal diseases.

The COVID-19 segment recorded 30.8% of the market share in 2023, attributed to the global demand for effective vaccines to combat the pandemic, government initiatives and substantial funding for mass vaccination campaigns.

North America respiratory disease vaccine industry size was USD 20.6 billion in 2023, driven by the advanced healthcare infrastructure, high vaccination coverage rates, strong government initiatives and funding for immunization programs.

Key firms operating in the respiratory disease vaccine industry are AstraZeneca, Emergent BioSolutions Inc., GSK plc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Novavax, Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., and SINOVAC, among others.